This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Navinta, LLC, Navinta III Inc. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gujarat, IN (2020)
- Vadodara, IN (2017 - 2023)
Company Filing History:
Years Active: 2017-2023
Title: Raja Jeyakumar John Muthiah: Innovator in Pharmaceutical Chemistry
Introduction
Raja Jeyakumar John Muthiah is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of highly pure compounds. With a total of 3 patents to his name, his work has had a considerable impact on the industry.
Latest Patents
Muthiah's latest patents include a process for the preparation of highly pure Salcaprozic Acid and its pharmaceutically acceptable salts. This innovative process utilizes novel reagents for the removal of colored impurities during the preparation of Salcaprozic Acid. The methods involve hydrolysis of 8-(2,4-dioxo-1,3-benzoxazin-3-yl)octanoic acid ethyl ester in the presence of benzotriazole, hydrazine, and/or sodium borohydride. Another significant patent is for the crystalline fosaprepitant dicyclohexylamine salt and its preparation. This patent outlines a process for preparing fosaprepitant DCHA and its use in creating pharmaceutically acceptable fosaprepitant dimeglumine with high purity.
Career Highlights
Throughout his career, Muthiah has worked with various companies, including Navinta, LLC and Navinta III Inc. His expertise in pharmaceutical processes has been instrumental in advancing the development of new medications.
Collaborations
Muthiah has collaborated with several professionals in his field, including Jigneshkumar Jasubhai Patel and Pankaj Vasudev Parmar. These collaborations have further enriched his research and development efforts.
Conclusion
Raja Jeyakumar John Muthiah is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the industry. His innovative processes and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
